9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Predictors of therapy failure in newly diagnosed pulmonary tuberculosis cases in Beira, Mozambique

      brief-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          Tuberculosis (TB) remains a major global health issue, ranking in the top ten causes of death worldwide. A deep understanding of factors influencing poor treatment outcomes may allow the development of additional treatment strategies, focused on the most vulnerable groups. Aims of the study were: (i) to evaluate the treatment outcome among TB subjects followed in an outpatient setting and (ii) to analyze factors associated with treatment failure in newly diagnosed patients with pulmonary TB in Beira, the second largest city of Mozambique.

          Results

          A total of 301 TB adult patients (32.6% females) were enrolled. Among them, 62 (20.6%) experienced a treatment failure over a 6 months follow-up. On multivariate model, being males (O.R. = 1.73; 95% CI 1.28–2.15), absence of education (O.R. = 1.85; 95% CI 1.02–2.95), monthly income under 50 dollars (O.R. = 1.74; 95% CI 1.24–2.21) and being employed (O.R. = 1.57; 95% CI 1.21–1.70), low body mass index values (O.R. = 1.42; 95% CI 1.18–1.72) and HIV status (O.R. = 1.42; 95% CI 1.10–1.78) increased the likelihood of therapy failure over 6 months of follow-up. In this study, patients who need more medical attention were young males, malnourished, with low income and low educational degree and HIV positive. These subjects were more likely to fail therapy.

          Related collections

          Most cited references13

          • Record: found
          • Abstract: found
          • Article: not found

          Tuberculosis and HIV Coinfection.

          Tuberculosis (TB) and human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) constitute the main burden of infectious disease in resource-limited countries. In the individual host, the two pathogens, Mycobacterium tuberculosis and HIV, potentiate one another, accelerating the deterioration of immunological functions. In high-burden settings, HIV coinfection is the most important risk factor for developing active TB, which increases the susceptibility to primary infection or reinfection and also the risk of TB reactivation for patients with latent TB. M. tuberculosis infection also has a negative impact on the immune response to HIV, accelerating the progression from HIV infection to AIDS. The clinical management of HIV-associated TB includes the integration of effective anti-TB treatment, use of concurrent antiretroviral therapy (ART), prevention of HIV-related comorbidities, management of drug cytotoxicity, and prevention/treatment of immune reconstitution inflammatory syndrome (IRIS).
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Successful TB treatment outcome and its associated factors among TB/HIV co-infected patients attending Gondar University Referral Hospital, Northwest Ethiopia: an institution based cross-sectional study

            Background Tuberculosis/Human immunodeficiency virus (TB/HIV) co-infection is bidirectional and synergistic which mainly affects interventions that have been taken on the area. Tb patients co-infected with HIV have poorer treatment outcome as compared to non-co-infected patients. There is limited information regarding successful TB treatment outcomes and its associated factors; a reason that this study was planned to investigate. Methods An institution based cross sectional study was carried out from July 2010 to January 2016. Data were abstracted from patients’ medical chart using data abstraction format. The completeness of the data was checked and cleaned manually. Then, it was entered and analyzed by using SPSS version 20.0. Bi-variable and Multi-variable logistic regression model was fitted to identify factors associated with successful Tb treatment outcome. Significance was obtained through adjusted odds ratio with its 95% CI and a p < 0.05. Results Successful TB treatment outcome among TB/HIV co-infected patients in Gondar University Hospital was 77.3% [95%CI 72.6–81.9]. Being residing in outside the Gondar town [AOR = 0.44, 95%CI: 0.25–0.80], having less than the mean baseline weight (<43.7 kg) at initiation of TB treatment [AOR = 0.51, 95% CI: 0.29–0.89], being in the bedridden condition [AOR = 0.23, 95% CI: 0.1–0.23], and experiencing anti-TB treatment side effect [AOR = 0.35, 95% CI: 0.12–0.98] were the factors that resulted the patient in treatment failure. Conclusion Successful Tb treatment outcome among TB/HIV co-infected patients was lower than the target set by Global Plan to Stop TB 2011–2015. Strengthening collaborative TB/HIV management activities that would trace the identified factors shall be recommended to increase successful treatment outcome of TB.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Social determinants of therapy failure and multi drug resistance among people with tuberculosis: A review.

              Social determinants influence health and the development of tuberculosis (TB). However, a paucity of data is available considering the relationship of social determinants influencing therapy failure and multi drug resistance (MDR). We conducted a review investigating the relationship of common social determinants on therapy failure and MDR in people with TB.
                Bookmark

                Author and article information

                Contributors
                d.pizzol@cuamm.org
                ilmannato@gmail.com
                claudia.marotta@unipa.it
                cicciodigennaro@yahoo.it
                jmoiane@ucm.ac.mz
                kajalchhaganlal@yahoo.co.uk
                laura.monno@uniba.it
                g.putoto@cuamm.org
                walter.mazzucco@unipa.it
                annalisa.saracino@gmail.com
                Journal
                BMC Res Notes
                BMC Res Notes
                BMC Research Notes
                BioMed Central (London )
                1756-0500
                5 February 2018
                5 February 2018
                2018
                : 11
                : 99
                Affiliations
                [1 ]Research Unit, Doctors with Africa-CUAMM, Beira, Mozambique
                [2 ]ISNI 0000 0004 1757 3470, GRID grid.5608.b, Department of Medicine (DIMED)-Geriatrics Section, , University of Padova, ; Padua, Italy
                [3 ]ISNI 0000 0004 1762 5517, GRID grid.10776.37, Department of Science for Health Promotion and Mother to Child Care “G. D’Alessandro”, , University of Palermo, ; via del Vespro, 133, Palermo, Italy
                [4 ]ISNI 0000 0001 0120 3326, GRID grid.7644.1, Department of Infectious Diseases, , University of Bari “Aldo Moro”, ; P.zza G Cesare 3, Bari, Italy
                [5 ]GRID grid.488436.5, Doctors with Africa-CUAMM, ; Padua, Italy
                [6 ]Faculty of Health Sciences, Catholic University of Mozambique, Center for Research in Infectious Diseases, Beira, Mozambique
                [7 ]GRID grid.488436.5, Research Section, , Doctors with Africa CUAMM, ; Padua, Italy
                Article
                3209
                10.1186/s13104-018-3209-9
                5800087
                29402317
                6d3b0ccf-b0e7-464a-8529-4f7314ee49e5
                © The Author(s) 2018

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 23 August 2017
                : 31 January 2018
                Categories
                Research Note
                Custom metadata
                © The Author(s) 2018

                Medicine
                tuberculosis,mozambique,therapy failure
                Medicine
                tuberculosis, mozambique, therapy failure

                Comments

                Comment on this article